Last Updated : June 17, 2024
The Pharmaceutical Advisory Committee comprises representatives from the federal, provincial, and territorial publicly funded drug plans and other related health organizations. The Pharmaceutical Advisory Committee provides strategic advice on drug policy issues, including cancer-specific issues and drug topics, to Canada’s Drug Agency and its Board. Committee members also facilitate the effective jurisdictional sharing of drug policy information.
Chair |
|
|---|---|
| Ontario Health | Scott Gavura |
Members |
|
| Government of Manitoba | Alan Lawless |
| Saskatchewan Ministry of Health | Marina Facci |
| British Columbia Ministry of Health | Tijana Fazlagic |
| British Columbia Cancer Agency | Helen Anderson |
| Alberta Health | Andrea Nagle |
| Ontario Ministry of Health | Angie Wong |
| Nova Scotia Department of Health and Wellness | Kathleen Coleman |
| New Brunswick Ministry of Health | Position Vacant |
| Prince Edward Island Department of Health and Wellness | Marsha Cusack |
| Newfoundland and Labrador Department of Health and Community Services | Pam Barnes |
| Nova Scotia Cancer Care Program | Joanne Houlihan |
| Government of Yukon Territory | Marie-Claire Savoie |
| Government of Nunavut | Position Vacant |
| Government of North West Territories | Luke Spooner |
| NIHB | Karen Fortin |
| Federal Drug Plans | Bassem Guirguis |
| Health Canada | Samir Khan |
| Hospital/Health Authority | Position Vacant |
| Forces | Michelle Sullivan |
| CAPCA | Vacant Position |
| INESSS | Sylvie Bouchard |
| pCPA | Dominic Tan |
| PMPRB | Tanya Potashnik |
Last Updated : June 17, 2024